Role of non-Smad signaling pathways in transforming growth factor beta (TGFβ)-induced expression of chondroitin sulfate proteoglycans (CSPGs) by reactive astrocytes

Autor: Jahan, Naima

Chondroitin sulphate proteoglycans (CSPGs) from the glial scar inhibit axonal regeneration following spinal cord injury. CSPG expression can be induced by transforming growth factor β (TGFβ), which suggests that inhibition of TGFβ may reduce CSPG

Externí odkaz: http://hdl.handle.net/1993/22301

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Expansion of cytotoxic tissue-resident CD8⁺ T cells and CCR6⁺CD161⁺ CD4⁺ T cells in the nasal mucosa following mRNA COVID-19 vaccination.

Autor: Ssemaganda, Aloysious, Nguyen, Huong Mai, Nuhu, Faisal, Jahan, Naima, Card, Catherine M., Kiazyk, Sandra, Severini, Giulia, Keynan, Yoav, Su, Ruey-Chyi, Ji, Hezhao, Abrenica, Bernard, McLaren, Paul J., Ball, T. Blake, Bullard, Jared, Van Caeseele, Paul, Stein, Derek, McKinnon, Lyle R.

Publikováno v: Nature Communications; 6/10/2022, Vol. 13 Issue 1, p1-9, 9p

Pre-HIV α4β7hi CD4+ T cells and HIV risk among heterosexual individuals in Africa.

Autor: Omole TE; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Nguyen HM; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Marcinow A; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Oo MM; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Jahan N; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Ssemaganda A; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Severini G; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada., Thomas KK; Departments of Global Health, University of Washington, Seattle, USA., Celum C; Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, USA., Mugo N; Departments of Global Health, University of Washington, Seattle, USA.; Kenya Medical Research Institute, Nairobi, Kenya., Mujugira A; Departments of Global Health, University of Washington, Seattle, USA.; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kublin J; HIV Vaccine Trials Network (HVTN), Seattle, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Corey L; HIV Vaccine Trials Network (HVTN), Seattle, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sivro A; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada.; Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, South Africa.; JC Wilt Infectious Disease Research Centre, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa., Lingappa JR; Departments of Global Health, Medicine, and Pediatrics, University of Washington, Seattle, USA., Gray G; HIV Vaccine Trials Network (HVTN), Seattle, USA.; South African Medical Research Council, Cape Town, South Africa., McKinnon LR; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Canada.; Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, South Africa.; Department of Medical Microbiology & Immunology, University of Nairobi, Nairobi, Kenya.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Dec 25. Date of Electronic Publication: 2024 Dec 25.